Latest Content

The needs of the nation's 63 million caregivers are rising on the public policy agenda, as bipartisan bills appear in the Congress to offer tax credits and other support.

At an AJMC roundtable, Boston clinicians detailed fragmented obesity care access, prior authorization burdens, and looming GLP-1 coverage shifts.

Novartis says it can deliver doses to treatment sites with 5 days of order.

The FDA approval of atacicept introduces the first BAFF/APRIL dual inhibitor for IgA nephropathy, with trial data showing significant proteinuria reduction.

The researchers of this study warn a mismatch could deepen care gaps for LGBTQ+ patients in restrictive states.

John Kitchens, MD, explores how GLP-1s, novel drug pipelines, and Medicaid access gaps are shaping the future of DME management.

Chronic skin disorders are psychologically impacting children and adolescents, reinforcing the need for routine mental health screening.

Brittany G. Craiglow, MD, FAAD, discusses the psychiatric and psychosocial toll of alopecia in children and adolescents, and its impact on treatment initiation.

Experts discussed innovations in oncology care, treatment access, pharmacy workflows, and patient outcomes.